Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival

L. Bancalari, S. Calafati, S. Cordani, F. Fiasella, R. Maggiani, P. Pronzato, P. A. Canessa (Sarzana, La Spezia, Italy)

Source: Annual Congress 2002 - Mesothelioma and malignant pleural effusion

Session: Mesothelioma and malignant pleural effusion
Session type: Thematic Poster Session
Number: 1740

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Bancalari, S. Calafati, S. Cordani, F. Fiasella, R. Maggiani, P. Pronzato, P. A. Canessa (Sarzana, La Spezia, Italy). Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival. Eur Respir J 2002; 20: Suppl. 38, 1740

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Malignant pleural mesothelioma clinical aspects and survival in 93 cases Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Survival time in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
Epidemiology, etiology, prognosis and presentation of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Treatment of malignant pleural mesothelioma with caelyx: few responses but good survival Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011
Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003
Malignant pleural mesothelioma (MPM) – 5 years of experience Source: Eur Respir J 2006; 28: Suppl. 50, 91s Year: 2006
Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005
Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017
PET predicts survival in malignant pleural mesothelioma Source: ISSN=ISSN 1810-6838, ISBN=, page=290 Year: 2007
Pathological diagnosis of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Malignant pleural effusion survival prognostication in an Asian population Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006
Management of malignant pleural mesothelioma Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012
Management of malignant pleural mesothelioma Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016
Management of malignant pleural mesothelioma Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013
Management of malignant pleural mesothelioma Source: ERS Skills Course 2015 Year: 2015
Management of malignant pleural mesothelioma Source: School Course 2014 - Medical Thoracoscopy Year: 2014